U.S. Markets close in 2 hrs 45 mins

OxySure Therapeutics, Inc. (OXYS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0062-0.00 (-21.52%)
As of 12:09PM EDT. Market open.
People also watch

OxySure Therapeutics, Inc.

10880 John West Elliott Drive
Suite 600
Frisco, TX 75033
United States

IndustryMedical Appliances & Equipment
Full Time Employees24

Key Executives

Mr. Julian T. Ross M.B.A.Founder, Chairman, CEO, Pres, CFO, Principal Accounting Officer and Sec.250kN/A50
Mr. Clark E. HoodVP of Worldwide Resuscitation Sales200kN/A54
Ms. Lisa GriffinDirector of Safety EducationN/AN/AN/A
Ms. Kathryn JayneDirector of Regulatory Affairs & Quality AssuranceN/AN/AN/A
Amounts are as of December 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


OxySure Therapeutics, Inc. designs, manufactures, and distributes specialty respiratory and emergency medical solutions in the United States and internationally. It offers OxySure Model 615, a portable emergency oxygen system. The company also provides complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. Its products enhance the access to emergency oxygen that affects the survival, recovery, and safety of individuals in various areas of need. The company primarily sells its products to institutional customers through distributors, sub-distributors, and sales agents. The company was formerly known as OxySure Systems, Inc. and changed its name to OxySure Therapeutics, Inc. in November 2015. OxySure Therapeutics, Inc. was founded in 2004 and is headquartered in Frisco, Texas. On December 5, 2016, Oxysure Therapeutics, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Eastern District of Texas.

Corporate Governance

OxySure Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.